Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727–33.

CAS  PubMed  PubMed Central  Google Scholar 

Rajnik M, Cascella M, Cuomo A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Uniformed Services University Of The Health Sciences; 2021.

Chen Y, Liu Q, Guo D. Emerging coronaviruses: genome structure, replication, and pathogenesis. J Med Virol. 2020;92(4):418–23.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Cui J, Li F, Shi Z-L. Origin and evolution of pathogenic coronaviruses. Nat Rev Microbiol. 2019;17(3):181–92.

CAS  PubMed  Article  Google Scholar 

Zhong N, Zheng B, Li Y, Poon L, Xie Z, Chan K, et al. Epidemiology and cause of severe acute respiratory syndrome (SARS) in Guangdong, People’s Republic of China, in February, 2003. Lancet. 2003;362(9393):1353–8.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1953–66.

CAS  PubMed  Article  Google Scholar 

Drosten C, Günther S, Preiser W, Van Der Werf S, Brodt H-R, Becker S, et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med. 2003;348(20):1967–76.

CAS  PubMed  Article  Google Scholar 

Song Z, Xu Y, Bao L, Zhang L, Yu P, Qu Y, et al. From SARS to MERS, thrusting coronaviruses into the spotlight. Viruses. 2019;11(1):59.

CAS  PubMed Central  Article  Google Scholar 

Seah I, Agrawal R. Can the coronavirus disease 2019 (COVID-19) affect the eyes? A review of coronaviruses and ocular implications in humans and animals. Ocul Immunol Inflamm. 2020;28(3):391–5.

CAS  PubMed  Article  Google Scholar 

Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol. 2020;45(8): 100618.

PubMed  PubMed Central  Article  Google Scholar 

Li G, He X, Zhang L, Ran Q, Wang J, Xiong A, et al. Assessing ACE2 expression patterns in lung tissues in the pathogenesis of COVID-19. J Autoimmun. 2020;112: 102463.

CAS  PubMed  PubMed Central  Article  Google Scholar 

World Health Organization. 2022. https://www.who.int/en/activities/tracking-SARS-CoV-2-variants.

International Committee on Taxonomy of Viruses (ICTV). 2022. https://talk.ictvonline.org/taxonomy/.

Ge X-Y, Yang W-H, Zhou J-H, Li B, Zhang W, Shi Z-L, et al. Detection of alpha-and betacoronaviruses in rodents from Yunnan. China Virol J. 2017;14(1):1–11.

Article  CAS  Google Scholar 

Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin. BioRxiv. 2020.01.22.914952.

Kumar S, Nyodu R, Maurya VK, Saxena SK. Morphology, genome organization, replication, and pathogenesis of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Coronavirus Disease 2019 (COVID-19): Springer; 2020. p. 23–31.

Chan JF-W, Kok K-H, Zhu Z, Chu H, To KK-W, Yuan S, et al. Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan. Emerg Microbes Infections. 2020;9(1):221–36.

Yang D, Leibowitz JL. The structure and functions of coronavirus genomic 3′ and 5′ ends. Virus Res. 2015;206:120–33.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wu F, Zhao S, Yu B, Chen Y-M, Wang W, Hu Y, et al. Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. BioRxiv 2020.01.24.919183.

Rahimi A, Mirzazadeh A, Tavakolpour S. Genetics and genomics of SARS-CoV-2: a review of the literature with the special focus on genetic diversity and SARS-CoV-2 genome detection. Genomics. 2021;113(1):1221–32.

CAS  PubMed  Article  Google Scholar 

Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271–80.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, et al. The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies. Cell Mol Biol Lett. 2022;27(1):10.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res. 2020;176: 104742.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Liu W, Li H. COVID-19: attacks immune cells and interferences with antigen presentation through MHC-like decoy system.

Mo P, Xing Y, Xiao Y, Deng L, Zhao Q, Wang H, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan. China Clin Infect Dis. 2020;73(11):e4208–13.

Article  CAS  Google Scholar 

Saberiyan M, Safi A, Kamel A, Movahhed-Abbasabad P, Miralimalek M, Afkhami H, et al. An overview on the common laboratory parameter alterations and their related molecular pathways in screening for COVID-19 patients. Clin Lab. 2020;66:10.

Article  Google Scholar 

Meng H, Xiong R, He R, Lin W, Hao B, Zhang L, et al. CT imaging and clinical course of asymptomatic cases with COVID-19 pneumonia at admission in Wuhan. China J Infect. 2020;81(1):e33–9.

CAS  PubMed  Article  Google Scholar 

Du Y, Tu L, Zhu P, Mu M, Wang R, Yang P, et al. Clinical features of 85 fatal cases of COVID-19 from Wuhan. A retrospective observational study. Am J Respir Crit Care Med. 2020;201(11):1372–9.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Ye M, Fu D, Ren Y, Wang F, Wang D, Zhang F, et al. Treatment with convalescent plasma for COVID-19 patients in Wuhan. China J Med Virol. 2020;92(10):1890–901.

CAS  PubMed  Article  Google Scholar 

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565–74.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Grint DJ, Wing K, Houlihan C, Gibbs HP, Evans SJ, Williamson E, et al. Severity of SARS-CoV-2 alpha variant (B. 1.1. 7) in England. Clin Infect Dis. 2021;7:754.

Article  Google Scholar 

Davies NG, Jarvis CI, Edmunds WJ, Jewell NP, Diaz-Ordaz K, Keogh RH. Increased mortality in community-tested cases of SARS-CoV-2 lineage B. 1.1.7. Nature. 2021;593(7858):270–4.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Deb P, Molla M, Ahmed M, Saif-Ur-Rahman K, Das MC, Das D. A review of epidemiology, clinical features and disease course, transmission dynamics, and neutralization efficacy of SARS-CoV-2 variants. Egypt J Bronchol. 2021;15(1):1–14.

Article  Google Scholar 

Tao K, Tzou PL, Nouhin J, Gupta RK, de Oliveira T, Kosakovsky Pond SL, et al. The biological and clinical significance of emerging SARS-CoV-2 variants. Nat Rev Genet. 2021;22(12):757–73.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Grabowski F, Preibisch G, Giziński S, Kochańczyk M, Lipniacki T. SARS-CoV-2 variant of concern 202012/01 has about twofold replicative advantage and acquires concerning mutations. Viruses. 2021;13(3):392.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, et al. Detection of a SARS-CoV-2 variant of concern in South Africa. Nature. 2021;592(7854):438–43.

CAS  PubMed  Article  Google Scholar 

Alkhatib M, Svicher V, Salpini R, Ambrosio FA, Bellocchi MC, Carioti L, et al. SARS-CoV-2 variants and their relevant mutational profiles: update summer 2021. Microbiol Spectrum. 2021;9(3):e01096-e1121.

CAS  Article  Google Scholar 

Zhou D, Dejnirattisai W, Supasa P, Liu C, Mentzer AJ, Ginn HM, et al. Evidence of escape of SARS-CoV-2 variant B. 1.351 from natural and vaccine-induced sera. Cell. 2021;184(9):2348–61.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Roquebert B, Trombert-Paolantoni S, Haim-Boukobza S, Lecorche E, Verdurme L, Foulongne V, et al. The SARS-CoV-2 B. 1.351 lineage (VOC β) is outgrowing the B. 1.1 7 lineage (VOC α) in some French regions in April 2021. Eurosurveillance. 2021;26(23):2100447.

CAS  PubMed Central  Article  Google Scholar 

Khan A, Khan T, Ali S, Aftab S, Wang Y, Qiankun W, et al. SARS-CoV-2 new variants: characteristic features and impact on the efficacy of different vaccines. Biomed Pharmacother. 2021;143: 112176.

CAS  PubMed  PubMed Central  Article  Google Scholar 

Focosi D. Spike Protein Mutations Detected in Currently Circulating Strains SARS-CoV-2 Spike Protein Convergent Evolution. Berlin: Springer; 2021. p. 27–54.

Book  Google Scholar 

He X, He C, Hong W, Zhang K, Wei X. The challenges of COVID-19 Delta variant: prevention and vaccine development. MedComm. 2021;2(4):846–54.

CAS  PubMed Central  Article  Google Scholar 

Hendaus MA, Jomha FA. Delta variant of COVID-19: a simple explanation. Qatar Med J. 2021;2021(3):49.

PubMed